Share
A2X welcomes new health ETF
Sygnia, a JSE-listed asset manager is listing a new Exchange Traded Fund on the A2X exchange. The ETF will provide local investors access to international assets. Joining CNBC Africa for more is Kevin Brady, A2X CEO.
Tue, 10 Aug 2021 10:42:41 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- The new health ETF listing on A2X will provide local investors with access to international assets and diversify their investment opportunities
- A2X aims to enhance liquidity, reduce spreads, and offer cost-effective trading options for investors through new listings
- The platform's strategic approach to engaging with institutions and expanding its listing pipeline reflects a commitment to promoting financial inclusion and market growth
A2X, a leading stock exchange platform, is set to welcome a new health Exchange Traded Fund (ETF) from Signia, a JSE-listed asset manager. The ETF will provide local investors with access to international assets, offering them a wider range of investment opportunities. In an exclusive interview with CNBC Africa, Kevin Brady, A2X CEO, shed light on the significance of this new listing and the positive impact it will have on investors.
Kevin Brady highlighted the benefits of the new ETF, mentioning that it will enhance liquidity and reduce spreads, ultimately leading to cost savings for investors. With the increasing demand for ETFs globally, A2X is tapping into this trend by providing local investors with a gateway to international healthcare investments. This move comes at a time when market volatility and uncertainty have driven investors to seek diversified and stable investment options.
Brady discussed the growing interest in actively managed ETFs in South Africa and mentioned ongoing conversations with institutions to introduce such offerings in the local market. While A2X mainly offers secondary listings, they are working towards enabling more investment options for South African investors by engaging with relevant authorities and stakeholders.
Regarding A2X's listing pipeline, Brady expressed optimism about upcoming listings in the second half of the year. Despite economic and pandemic headwinds, A2X has seen steady growth, with a total of 54 securities listed and 15 new listings this year. The CEO hinted at potential big names entering the market soon, especially in the financial and retail sectors.
As A2X continues to expand its offerings, it aims to maintain momentum and attract a diverse range of companies across various industries. With 36 companies already listed on the platform, A2X has positioned itself as a key player in the African market, boasting a market capital of 4.3 trillion.
Brady also touched on the impact of delistings from the Johannesburg Stock Exchange (JSE) on A2X, noting that smaller companies are facing challenges in finding value in traditional listings. He emphasized the importance of capital markets players adapting to international best practices and fostering a supportive environment for companies to thrive.
In response to the JSE's initiative to help smaller companies raise capital more efficiently, Brady acknowledged the need for industry players to collaborate and enhance the market ecosystem. While A2X focuses on secondary listings, the platform recognizes the importance of aligning with global standards and regulations to facilitate sustainable growth and investor protection.
Overall, A2X's collaboration with Signia to introduce a new health ETF exemplifies the platform's commitment to diversifying investment options and promoting financial inclusion. As the market landscape evolves, A2X remains at the forefront of driving innovation and expanding access to international assets for South African investors.
SIGN UP FOR OUR NEWSLETTER
DAILY UPDATE
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.